Dr. Peter Nicholas Kao, MD

Dr. Kao practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Kao's NPI, 1568504686, was assigned on February 13, 2007. Dr. Kao graduated from Vagelos College of Physicians and Surgeons in 1988. Dr. Kao holds California license G67731.

Dr. Kao's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Kao's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Kao to 1 more hospital, named with a free account. Dr. Kao's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kao practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kao's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kao is board certified in pulmonary disease by the American Board of Internal Medicine. Dr. Kao is licensed in California.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pneumonia, pulmonary fibrosis, pulmonary heart disease and sleep apnea among the conditions Dr. Kao treats.

CMS data shows 251 Medicare services from Dr. Kao across 2 procedure codes in 2024, all of them office visits, for 174 Medicare patients. Medicare paid $21,559 for them.

CMS counts 174 Medicare patients who saw Dr. Kao in 2024. The largest group is 75 to 84, with 68 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kao's median patient age at 72, with 57% women.

In 2024, Dr. Kao wrote 789 Medicare Part D claims for 117 patients. 61% of them were for generic drugs. CMS names the drug for 614 of them, across 21 drugs with 11 or more claims each, at $328,116 in total drug cost. In 2023, CMS named 597 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kao for performance year 2024, reported as part of a group. Dr. Kao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kao as offering telehealth.

Dmand AI links 44 papers to Dr. Kao, published from 2002 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Nuclear Factor 90 Proteins, DNA-Binding Proteins and Gene Expression Regulation. Dr. Kao has published most often in J Biol Chem. Dr. Kao's most frequent co-authors are Gerald J. Berry, MD, Ronald Gary Pearl, MD, PhD and Stephen J. Ruoss, MD.

CMS Open Payments shows 1 general payment to Dr. Kao from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $12.

Dmand AI lists 1 award for Dr. Kao, most recently CMS Stage 1 EHR in 2013.

Dr. Kao graduated from Vagelos College of Physicians and Surgeons in 1988.

Dr. Kao is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.